期刊
CANCER RESEARCH
卷 77, 期 21, 页码 E123-E126出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-17-0341
关键词
-
类别
资金
- NIH [T32 CA101642]
- Cancer Prevention and Research Institute of Texas [RP150535]
- Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
- NCATS [UL1 TR000371]
- Bosarge Family Foundation
- MD Anderson Cancer Center Support Grant [P30 CA016672]
- [1U01 CA180964]
High-throughput genomic and molecular profiling of tumors is emerging as an important clinical approach. Molecular profiling is increasingly being used to guide cancer patient care, especially in advanced and incurable cancers. However, navigating the scientific literature tomake evidence-based clinical decisions based on molecular profiling results is overwhelming for many oncology clinicians and researchers. The Personalized Cancer Therapy website (www. personalizedcancertherapy. org) was created to provide an online resource for clinicians and researchers to facilitate navigation of available data. Specifically, this resource can be used to help identify potential therapy options for patients harboring oncogenic genomic alterations. Herein, we describe how content on www. personalized cancertherapy. org is generated and maintained. We end with case scenarios to illustrate the clinical utility of the website. The goal of this publicly available resource is to provide easily accessible information to a broad oncology audience, as thismay help ease the information retrieval burden facing participants in the precision oncology field. (C) 2017 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据